Flex Pharma, Inc. (NASDAQ:FLKS) went up by 19.09% from its latest closing price when compared to the 1-year high value of $1.74 and move down -171.88%, while FLKS stocks collected +30.61% of gains with the last five trading sessions.
FLKS Market Performance
FLKS stocks went up by 30.61% for the week, with the monthly jump of 58.93% and a quarterly performance of 84.52%, while its annual performance rate touched -84.69%. The simple moving average for the period of the last 20 days is 41.04% for FLKS stocks with the simple moving average of 47.12% for the last 200 days.
Analysts’ Opinion on Flex Pharma, Inc. (NASDAQ:FLKS)
Many brokerage firms have already submitted their reports for FLKS stocks, with Ladenburg Thalmann repeating the rating for FLKS shares by setting it to “Neutral”. The predicted price for FLKS socks in the upcoming period according to Ladenburg Thalmann is $52 based on the research report published on June 13, 2018.
Ladenburg Thalmann, on the other hand, stated in their research note that they expect to see FLKS stock at the price of $12. The rating they have provided for FLKS stocks is “Buy” according to the report published on January 25, 2018.
ROTH Capital gave “Buy” rating to FLKS stocks, setting the target price at $12 in the report published on January 3, 2018.
FLKS Stocks 36.98% Far from 50 Day Moving Average
After a stumble in the market that brought FLKS to its low price for the period of the last 52 weeks, Flex Pharma, Inc. was unable to take a rebound, for now settling with -63.22% of loss for the given period.
The stock volatility was left at 10.57%, however, within the period of a single month, the volatility rate increased by 14.02%, while the shares surge at the distance of +59.56% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by +45.45% upper at the present time.
In the course of the last 5 trading sessions, FLKS went up by +30.61%, which changed the moving average for the period of 200 days to the total of +20.75% of gains for the stock in comparison to the 20-day moving average settled at $0.47. In addition, Flex Pharma, Inc. saw 94.00% in overturn over the period of a single year with a tendency to cut further gains.
FLKS Stock Insider Trading
Reports are indicating that there were more than several insider trading activities at Flex Pharma, Inc. (FLKS), starting from Boston Foundation, Inc., who sold 337,000 shares at the price of $0.37 back on Jan 09. After this action, Rushing now owns 1,600,000 shares of Flex Pharma, Inc., valued at $123,848 with the latest closing price.
Boston Foundation, Inc., the 10% Owner of Flex Pharma, Inc., sold 263,000 shares at the value of $0.40 during a trade that took place back on Jan 08, which means that Boston Foundation, Inc. is holding 1,937,000 shares at the value of $104,306 based on the most recent closing price.
FLKS Stock Fundamentals
The current profitability levels are settled at -2467.91 for the present operating margin and +48.61 for gross margin. The net margin for Flex Pharma, Inc. stands at -2615.57. Total capital return value is set at -107.76, while invested capital returns managed to touch -114.21. Equity return holds the value -155.30%, with -128.10% for asset returns.
The receivables turnover for Flex Pharma, Inc. is 82.48 with the total asset turnover at the value of 0.04. The liquidity ratio also appears to be rather interesting for investors as it stands at 9.32.